Reich O M, Faul P
Klinikum Memmingen, Urologische Klinik.
Z Arztl Fortbild Qualitatssich. 1998 Jun;92(5):311-8.
Despite the high incidence and the intensive research, the appropriate diagnostic and therapeutic approach for prostatic carcinoma (PCA) is still controversial. PSA and its new subtests allow earlier diagnosis of PCA. No rigid guidelines can be given concerning therapy. The therapeutic regimen has always to be adapted to the patient's individual needs and situation. For organ-confined and progressive disease, new concepts have been introduced. They seem to improve quality of life rather than to achieve prolonged survival.
尽管前列腺癌（PCA）发病率高且研究密集，但针对其的适当诊断和治疗方法仍存在争议。前列腺特异性抗原（PSA）及其新的子检测方法可实现PCA的早期诊断。关于治疗，无法给出严格的指导方针。治疗方案总是必须根据患者的个体需求和情况进行调整。对于器官局限性和进展性疾病，已经引入了新的概念。这些概念似乎改善了生活质量，而非延长生存期。
